All Stories

  1. The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome
  2. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
  3. Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships
  4. Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
  5. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
  6. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
  7. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
  8. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice
  9. Pan-cancer analysis of whole genomes
  10. The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome
  11. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
  12. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
  13. Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
  14. Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
  15. Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort
  16. Refinement of breast cancer molecular classification by miRNA expression profiles
  17. Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration
  18. Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time
  19. Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors
  20. Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
  21. Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer
  22. Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B
  23. Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration
  24. Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
  25. Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
  26. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
  27. Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
  28. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013
  29. Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
  30. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy
  31. Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing
  32. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells
  33. Abstract P6-08-43: Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013
  34. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
  35. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
  36. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
  37. Processed pseudogenes acquired somatically during cancer development
  38. Acute pancreatitis evoked by small-cell lung carcinoma metastases and detected by endoscopic ultrasound
  39. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
  40. G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua
  41. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall
  42. Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2
  43. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle
  44. Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator Receptor
  45. Breast metastases from pancreatic and ovarian carcinoma